• Designed for optimized workflows to support earlier detection of patient deterioration
• Future-ready device features customizable configurations and upgrade capabilities
• Connects to Baxter’s cloud-based platform DeviceBridge, helping to enable quick, secure transfer of vital signs data to electronic medical records

DEERFIELD, Ill.--(BUSINESS WIRE)--Sep. 16, 2025-- Baxter International Inc. (NYSE:BAX), a leading global medtech company, today launched the Welch AllynConnex 360 Vital Signs Monitor, its next generation patient monitoring device. As the latest innovation in Baxter’s connected monitoring portfolio, Connex360 offers an advanced connectivity and security platform, customizable configurations based on a hospital’s clinical routines, and upgrade capabilities that set the stage for future functionality and enhancements. With automated clinical documentation, Connex 360 is designed to simplify the clinician experience and allow more time to focus on patients.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916273572/en/

Baxter's Welch Allyn Connex 360 Vital Signs Monitor

“There is nothing more important than keeping patients safe, especially when time is of the essence,” said Julie Foster, president of Front Line Care at Baxter. “Care teams rely on vital signs monitoring to help detect changes in their patients’ conditions and make informed decisions. With Connex 360, we are advancing patient monitoring to provide care teams with the timely insights they need at the bedside, so they can make the most of every moment with their patients.”

In today’s complex healthcare environment, care teams and hospital staff are being asked to do more with less, and timely, accurate, and secure patient information is critical. Baxter’s Connex 360 monitor captures vital signs for adult, pediatric and neonate patients, including blood pressure, temperature, pulse rate, respiration rate¹ and blood oxygen levels.² Designed for optimized workflows, care teams can obtain a full set of patient vitals in less than one minute and automatically send to the electronic medical record, helping to reduce manual data entry errors and support informed care decisions.

This secure data flow is powered by Baxter’s cloud-based DeviceBridge platform, which works behind the scenes to help enable accurate data transfer from Connex360 to hospital IT systems, including the EMR. DeviceBridge also helps supportsecure device access andclinical data interoperability across Baxter’s ecosystem of connected devices.

Additional key features of Connex 360 include:

• Comprehensive security: Enhanced security features, including end-to-end encryption and certificate-based authentication, help protect patient and facility information.
• Intuitive interface: Baxter’s largest and most responsive color touchscreen allows intuitive navigation and the ability to see more patient data on one screen.
• Enhanced customization: Customizable Early Warning Score protocols alert clinicians to patient deterioration or changes in condition, and fully configurable monitoring modes support the individual needs of the patient.
• Easy upgrades and maintenance: Software upgrades for clinical, operational, and cybersecurity enhancements are streamlined, helping to reduce the burden on hospital IT teams and allowing for enhanced functionality over time.

Baxter expanded its presence in the patient monitoring space through its acquisition of Hillrom and the Welch Allyn portfolio. Welch Allyn has a longstanding history of delivering innovative patient monitoring solutions that support patient care across healthcare settings, from hospitals to outpatient care. Baxter has continued to invest in connected monitoring, with Connex 360 joining the company’s trusted lineup of vital signs solutions. The Connex 360 monitor received U.S. Food and Drug Administration 510(k) clearance and is now available for hospitals and health systems to order in the U.S.Learn more here.

About Baxter

At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in the hospital, physician’s office and other sites of care. For nearly a century, our customers have counted on us as a vital and trusted partner. And every day, millions of patients and healthcare providers rely on our unmatched portfolio of connected solutions, medical devices, and advanced injectable technologies. Approximately 38,000 Baxter team members live our enduring Mission: to Save and Sustain Lives. Together, we are redefining how care is delivered to make a greater impact today, tomorrow, and beyond. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.

Rx Only. For safe and proper use of the product mentioned herein, please refer to the appropriate Operator’s Manual or Instructions for Use.

This release includes forward-looking statements concerning potential benefits associated with Welch AllynConnex360 and DeviceBridge. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: demand for and market acceptance for new and existing products; product development risks; inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of natural disasters, public health crises and epidemics/pandemics, regulatory actions or otherwise); satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter's most recent filing on Form 10-K and Form 10-Q and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.

Baxter, Connex 360, DeviceBridge, Hillrom and Welch Allyn are trademarks of Baxter International Inc.

¹ Digitally measure respiration rate with Masimo RRp, for patients greater than two years old.
² For a system configured with the Masimo SpO2 module and the SpO2 sensor RRp measurement option, the noninvasive measurement of Respiration Rate is not intended to be used for neonatal/infant patients.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250916273572/en/

Media Contact
Natalie Matthews, (224) 948-5353
media@baxter.com

Investor Contact
global_corp_investor_relations@baxter.com

Source: Baxter International Inc.